News Related to CSPC Pharmaceutical Group

Related coverage linked through entity extraction aliases.

CSPC Pharmaceutical Receives China Approvals for Three Clinical Trials

Mar 05, 2026

CSPC Pharmaceutical Group has received approval from China's National Medical Products Administration to begin clinical trials for three drug candidates: a hemophilia A biosimilar, a long-acting pain medication, and an injection designated SYH9089.

China Biotech Licensing Deals Set to Hit Record in 2026 as Global Drugmakers Seek New Pipelines

Feb 13, 2026

Global pharmaceutical companies are accelerating licensing deals for China-developed experimental medicines, with deal values reaching unprecedented levels in 2026 as firms cut costs ahead of patent expirations.